NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1088 coverNeuroendocrine and Immune Crosstalk Volume 1088 published November 2006
Ann. N.Y. Acad. Sci. 1088: 319–334 (2006). doi: 10.1196/annals.1366.001
Copyright © 2006 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by BEUSCHLEIN, F.
Articles by REINCKE, M.
Search for Related Content
PubMed
PubMed Citation
Articles by BEUSCHLEIN, F.
Articles by REINCKE, M.

Part VII. The Adrenal Connection in Neuroimmunoendocrinology

Adrenocortical Tumorigenesis

FELIX BEUSCHLEINa AND MARTIN REINCKEa

a Medizinische Klinik–Innenstadt, Ludwig-Maximilians-University, Munich, Germany

Key Words: adrenal tumorigenesis • adrenocortical carcinoma • adrenocortical adenoma • adrenal incidentaloma • steroidogenesis • Cushing's syndrome • Conn's syndrome • hyperaldosteronism • p53 • IGF-1 • activin • inhibin

Address for correspondence: Dr. Martin Reincke, Medizinische Klinik–Innenstadt, Klinikum der LMU München, Ziemssenstr. 1, D-80336 München, Germany. Voice: +49-89-51602100; fax: +49-89-51604428.  e-mail: martin.reincke{at}med.uni-muenchen.de

Through the widespread use of imaging techniques with great sensitivity adrenal tumors are often diagnosed as an incidental finding. Although the majority of these adrenal lesions are benign and without evidence of endocrine activity or malignancy, hormone hypersecretion needs to be ruled out by specific tests. In addition to the classical forms of overt adrenocortical hypersecretion, it has become evident over the recent years that modest adrenocortical steroid autonomy as present in normokalemic primary aldosteronism and subclinical Cushing's syndrome is also associated with a significant morbidity. However, detection and differential diagnosis of these subtle changes in adrenal steroidogenesis can pose a diagnostic challenge to the clinician and is dependent on tests with reliable sensitivity and specificity. Regulation of adrenocortical development and growth, which results in clinical symptoms if disrupted, is dependent upon the distinct spatiotemporal expression of a variety of transcription factors as well as stimulation by extra-adrenal peptide hormones. Contributions to the elucidation of growth regulation of the adrenal cortex come from rare familiar syndromes associated with adrenocortical tumors, expression studies of adrenal tumor samples, in vitro studies on adrenocortical tumor cell lines, and mouse models displaying adrenal growth defects. In this review, we will summarize the important molecular aspects of adrenal tumorigenesis and highlight some prospects for clinical applications.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
R. Libe, A. Fratticci, J. Coste, F. Tissier, A. Horvath, B. Ragazzon, F. Rene-Corail, L. Groussin, X. Bertagna, M. L. Raffin-Sanson, et al.
Phosphodiesterase 11A (PDE11A) and Genetic Predisposition to Adrenocortical Tumors
Clin. Cancer Res., June 15, 2008; 14(12): 4016 - 4024.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
P. S. H. Soon, K. L. McDonald, B. G. Robinson, and S. B. Sidhu
Molecular Markers and the Pathogenesis of Adrenocortical Cancer
Oncologist, May 1, 2008; 13(5): 548 - 561.
[Abstract] [Full Text] [PDF]



footerLeft footerRight